BMC Cancer Oncology

Study protocol of a randomised phase II trial of concurrent stereotactic body radiotherapy with immunotherapy versus immunotherapy alone in patients with 1–5 extracranial melanoma oligometastases (AXIOM)

Angela M. Hong, Tim Wang, Matteo S. Carlino, Serigne N. Lo, Alexander M. Menzies, Inês Pires da Silva, Georgina V. Long
Springer Nature · 2025-10-21 · DOI 10.1186/s12885-025-15066-z

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →